79 related articles for article (PubMed ID: 3525789)
1. The occurrence and clinicopathological significance of serotonin immunoreactive cells in large bowel carcinoma.
Arends JW; Wiggers T; Verstijnen K; Bosman FT
J Pathol; 1986 Jun; 149(2):97-102. PubMed ID: 3525789
[TBL] [Abstract][Full Text] [Related]
2. [Immunohistochemical and clinicopathological studies of chromogranin immunoreactive cells in large bowel carcinoma].
Oishi A
Nihon Geka Gakkai Zasshi; 1989 Oct; 90(10):1742-51. PubMed ID: 2594002
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer or colon and rectal cancer? Clinicopathological comparison between colonic and rectal carcinomas.
Li M; Li JY; Zhao AL; Gu J
Oncology; 2007; 73(1-2):52-7. PubMed ID: 18334831
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological prognostic indicators with colorectal mucinous carcinomas.
Kubota K; Akasu T; Fujita S; Sugihara K; Moriya Y; Yamamoto S
Hepatogastroenterology; 2004; 51(55):142-6. PubMed ID: 15011850
[TBL] [Abstract][Full Text] [Related]
5. Comparison of phenotypic and genotypic features in human primary large bowel carcinomas and lymph node metastases.
Arends JW; Schutte B; Wiggers T; Verstijnen CP; Blijham GH; Bosman FT
Cancer Res; 1987 Aug; 47(16):4342-4. PubMed ID: 3475170
[TBL] [Abstract][Full Text] [Related]
6. [Immunocytochemical study of enterochromaffin cells in carcinoma of the large intestine].
Chen PH
Zhonghua Bing Li Xue Za Zhi; 1990 Jun; 19(2):86-9. PubMed ID: 1975223
[TBL] [Abstract][Full Text] [Related]
7. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of CEA immunoreactivity patterns in large bowel carcinoma tissue.
Wiggers T; Arends JW; Verstijnen C; Moerkerk PM; Bosman FT
Br J Cancer; 1986 Sep; 54(3):409-14. PubMed ID: 3756077
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine cells in colorectal adenomas.
Van den Ingh HF; Van den Broek LJ; Verhofstad AA; Bosman FT
J Pathol; 1986 Mar; 148(3):231-7. PubMed ID: 2871146
[TBL] [Abstract][Full Text] [Related]
10. Incidence, therapy and prognosis of colorectal cancer in different age groups. A population-based cohort study of the Rostock Cancer Registry.
Fietkau R; Zettl H; Klöcking S; Kundt G
Strahlenther Onkol; 2004 Aug; 180(8):478-87. PubMed ID: 15292968
[TBL] [Abstract][Full Text] [Related]
11. Colorectal carcinoma: importance of clinical and pathological factors in survival.
Deans GT; Patterson CC; Parks TG; Spence RA; Heatley M; Moorehead RJ; Rowlands BJ
Ann R Coll Surg Engl; 1994 Jan; 76(1):59-64. PubMed ID: 8117023
[TBL] [Abstract][Full Text] [Related]
12. p21WAF1/CIP1 expression in colorectal carcinoma correlates with advanced disease stage and p53 mutations.
Viale G; Pellegrini C; Mazzarol G; Maisonneuve P; Silverman ML; Bosari S
J Pathol; 1999 Feb; 187(3):302-7. PubMed ID: 10398083
[TBL] [Abstract][Full Text] [Related]
13. [S-phase fraction and malignant potential in DNA diploid colorectal cancer].
Ando Y; Tsuchiya A; Watanabe F; Sato H; Kikuchi Y; Yoshida T; Kimijima I; Abe R
Gan To Kagaku Ryoho; 1993 Apr; 20(6):771-4. PubMed ID: 8489284
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of intratumoral microvessel density, p53 expression and survival in colorectal cancer.
Vermeulen PB; Van den Eynden GG; Huget P; Goovaerts G; Weyler J; Lardon F; Van Marck E; Hubens G; Dirix LY
Br J Cancer; 1999 Jan; 79(2):316-22. PubMed ID: 9888475
[TBL] [Abstract][Full Text] [Related]
15. Microsatellite instability in sporadic colon carcinomas has no independent prognostic value in a Belgian study population.
Deschoolmeester V; Van Damme N; Baay M; Claes K; Van Marck E; Baert FJ; Wuyts W; Cabooter M; Weyler J; Vermeulen P; Lardon F; Vermorken JB; Peeters M
Eur J Cancer; 2008 Oct; 44(15):2288-95. PubMed ID: 18707864
[TBL] [Abstract][Full Text] [Related]
16. [Pathologic findings in colorectal cancers and discussion of their significance for tumor therapy according to stage].
Klimpfinger M; Beham A; Denk H
Wien Klin Wochenschr; 1987 Jul; 99(14):488-93. PubMed ID: 3630179
[TBL] [Abstract][Full Text] [Related]
17. The influence of tumour cell DNA abnormalities on survival in colorectal cancer.
Armitage NC; Robins RA; Evans DF; Turner DR; Baldwin RW; Hardcastle JD
Br J Surg; 1985 Oct; 72(10):828-30. PubMed ID: 4041716
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of receptor-binding cancer antigen expressed on SiSo cells (RCAS1) expression in relation to cadherin expression in patients with colorectal carcinoma.
Tsujitani S; Saito H; Honboh T; Ataka M; Tanida T; Makino M; Ikeguchi M
Dis Colon Rectum; 2007 Aug; 50(8):1241-9. PubMed ID: 17429708
[TBL] [Abstract][Full Text] [Related]
19. Ploidy and proliferation patterns in colo-rectal adenocarcinomas related to Dukes' classification and to histopathological differentiation. A flow-cytometric DNA study.
Tribukait B; Hammarberg C; Rubio C
Acta Pathol Microbiol Immunol Scand A; 1983 Mar; 91(2):89-95. PubMed ID: 6846020
[TBL] [Abstract][Full Text] [Related]
20. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance.
de Bruïne AP; Wiggers T; Beek C; Volovics A; von Meyenfeldt M; Arends JW; Bosman FT
Int J Cancer; 1993 Jul; 54(5):765-71. PubMed ID: 8100808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
